ERBB2 and endometrial cancer: To examine the linkage between HER-2 and the PI3K–AKT pathway, a knockdown of HER-2 was performed in the endometrial cancer cell line Ishikawa, using siRNA techniques, and the expression of p-AKT was evaluated by western blot analysis.